Alnylam Pharmaceuticals, SEC, Truist Financial, and Nasdaq were involved in insider trading disclosures, analyst ratings, and stock trading on June 6, 2026.
2 reports, 2 independent
Updated Sep 1
Gone quiet
- Reports
- 2
- Developments
- 2
- Repetition
- 0%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Alnylam Pharmaceuticals, SEC, Truist Financial, and Nasdaq were involved in insider trading disclosures, analyst ratings, and stock trading on June 6, 2026.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.Jeffrey Yu disclosed insider transactions to the SEC, while MarketBeat provided company ratings.1 source
Alnylam Pharmaceuticals was involved in insider trading disclosures and stock trading on Nasdaq.1 source
Keep exploring
The entities involved
-
Alnylam Pharmaceuticals
biopharmaceutical company
-
SEC
Slovak company
-
Jeffrey Yu
researcher
Nothing else this week.
-
MarketBeat
American personal finance blog
Related events
- Sprout Social disclosed insider transactions with the SEC while trading on the NASDAQ stock exchange.
- Grainger disclosed insider trading activity via SEC filings on July 31, 2026.
- Arrive AI traded on the Nasdaq stock exchange, with its performance covered by financial blog MarketBeat.
- Insider transaction disclosed to the SEC, concurrent with MarketBeat reporting a consensus rating for Newsmax Media.
- BioPharma stock was traded on the NASDAQ stock exchange on July 30, 2026, with its performance tracked by financial blogs.